Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:284-291
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, Y.
Right arrow Articles by Oshima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, Y.
Right arrow Articles by Oshima, T.

A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study

Yukihito Higashi, MD, PhD*, Shota Sasaki, MD*, Keigo Nakagawa, MD*, Tomohiro Ueda, MD*, Atsunori Yoshimizu, MD*, Satoshi Kurisu, MD*, Hideo Matsuura, MD, PhD*, Goro Kajiyama, MD, PhD* and Tetsuya Oshima, MD, PhD{dagger}

* First Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, Japan
{dagger} Department of Clinical Laboratory Medicine, Hiroshima University School of Medicine, Hiroshima, Japan



View larger version (22K):

[in a new window]
 
Figure 1 Forearm blood flow at rest and during reactive hyperemia in the normotensive control subjects (n = 47), hypertensive patients treated with calcium antagonists (n = 175), ACE inhibitors (n = 51), beta-blockers (n = 14) and diuretic agents (n = 10) and untreated hypertensive patients (n = 46). Reactive hyperemia was impaired in hypertensive patients as compared with normotensive subjects (p < 0.01). Reactive hyperemia was greater in hypertensive patients treated with ACE inhibitors than in those treated with calcium antagonists (p < 0.01), beta-blockers (p < 0.01) and diuretic agents (p < 0.05) and untreated hypertensive patients (p < 0.01). Reactive hyperemia was similar among calcium antagonist, beta-blocker, diuretic agent and untreated groups.

 


View larger version (18K):

[in a new window]
 
Figure 2 Maximal forearm blood flow after the sublingual administration of NTG in normotensive control subjects (n = 47), hypertensive patients treated with calcium antagonists (n = 175), ACE inhibitors (n = 51), beta-blockers (n = 14) and diuretic agents (n = 10) and untreated hypertensive patients (n = 46). Nitroglycerin-induced vasodilation was similar in all six groups.

 


View larger version (27K):

[in a new window]
 
Figure 3 Forearm blood flow at rest and during reactive hyperemia after the administration of L-NMMA, an NO synthase inhibitor, or indomethacin, a prostaglandin synthesis inhibitor, in hypertensive patients treated with ACE inhibitors (n = 13) or other agents (n = 15) and in untreated hypertensive patients (n = 18). L-NMMA abolished the enhancement of reactive hyperemia in hypertensive patients treated with ACE inhibitors (top). Indomethacin did not affect reactive hyperemia in any group (bottom).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement